NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

You people really did some great due diligence on DCVax. I mean that. I have learned a lot from you people about this important vaccine treatment. Unfortunately, all of us completely dropped the ball when it came to doing due diligence on the people running NWBO. That will be our downfall.

Amazing to watch UCLA take off with a Dendritic cell study of their own that has nothing to do with NWBO. People here keep acting like it does, but the UCLA study is completely divorced from NWBO. The people who claim otherwise are lying. In fact, while UCLA is using a vaccine that is similar to DCVax, they went out of their way to not call it by the name that NWBO gave it. No, for some reason UCLA is calling it a Dendritic Cell Tumor Cell Lysate Vaccine. What's remarkable is that the official trial record on clinicaltrials.gov requires them to list all alternative names for the drug. For instance, the study is also using Pembrolizumab, and for an alternative name it lists "Keytruda." So, naturally, you would think that a list of alternate names for Dendritic Cell Tumor Cell Lysate Vaccine would at the very least include "DCVax-L". But no, there is no listing of DCVax-L to be found. That's because UCLA has moved on from NWBO. They don't need them anymore, and are tired of waiting around while the company plays games while people's lives are on the line. If you don't believe me you can see for yourself if you click here.

And now we see a huge deal to purchase Cognate, a company that moved on from NWBO a long time ago - after almost suing them, LOL. Still collects a monthly fee from them for doing nothing, but just like UCLA, Cognate doesn't need NWBO in the least. In fact, from their most recent press release before this one, they have totally expanded their operations and have multiple new vaccines lined up for production, none of which include DCVax.

As NWBO fiddles, the world moves on. Meanwhile, we put our trust in a bunch of liars. That was our mistake.